Green tea compounds could soothe radiation burns in cancer care

NCT ID NCT07149506

ENROLLING_BY_INVITATION Symptom relief Sponsor: CARLOS FRANCISCO SAAVEDRA GARCIA Source: ClinicalTrials.gov ↗

First seen Jun 26, 2026 · Last updated Jun 26, 2026

Summary

This Phase 3 trial tests whether catechins (compounds found in green tea) given as a pill or spray can prevent or treat skin damage caused by radiation therapy. About 162 cancer patients will receive either catechins or a placebo, alongside standard care. The goal is to see if these natural compounds reduce redness, pain, and long-term scarring.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance: catechins (epicatechin and epigallocatechin gallate)
What this could lead to: If it works, this could offer a simple, accessible way to reduce skin damage from radiation therapy, improving comfort and quality of life for cancer patients.
What could go wrong: This is a single, relatively small Phase 3 trial in Mexico. Catechins may not prove more effective than placebo, and results may not apply to other populations.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for FIBROSIS; SKIN are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

cutaneous sclerosis Fibrosis localized scleroderma radiodermatitis

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

FIBROSIS; SKIN RADIATION DERMATITIS RADIATION DERMATITIS ACUTE

Contacts and locations

Locations

HRAEB

León, Guanajuato, 37544, Mexico

More trials for these conditions

Other studies related to the condition(s) this trial covers.